A leading heart doctor has raised new alarms over a common chemical found in the capsule shells of many daily medications, including pain relievers and vitamins, warning it could contribute to sudden heart attacks. The physician, a cardiologist affiliated with a major New York hospital, told the Daily Mail that phthalates—plasticizers often used to make soft gel capsules flexible—can enter the body, irritate arteries, and trigger inflammation, making it harder for blood to flow and heightening the risk of heart disease and cardiac events. This revelation is backed by a growing body of research suggesting a connection between the widespread use of phthalates in medications and increased cardiovascular threats.
Phthalates, commonly known as plasticizers, are chemical compounds utilized to soften and improve the flexibility of plastics. They are widely used not only in consumer goods and food packaging but also in the pharmaceutical industry, particularly in the outer coating of medical capsules. In Thailand, these capsules are among the most ubiquitous forms for delivering over-the-counter and prescription medications—from multivitamins and popular painkillers to treatments for common colds. The scale of exposure is vast: The US soft gel capsule market alone was valued at over $2 billion in 2022, with similar trends throughout Asia (dailymail.co.uk).
The significance for Thai consumers is considerable, given the nation’s growing pharmaceutical consumption and high rates of self-medication. Capsule-form medications are a mainstay in many Thai households, pharmacies, and hospital dispensaries. This means ordinary people of all ages may unknowingly ingest phthalates on a regular basis, accumulating potential health risks over years of seemingly routine medication use.
Recent research adds credibility to the warning. A 2021 study published in Environmental Pollution analyzed the urine of more than 5,300 adults ages 55 to 64, tracking health outcomes over several years. The findings showed that higher phthalate exposure corresponded with a greater likelihood of dying from cardiovascular disease, even after controlling for other risk factors (dailymail.co.uk). Additional studies reviewed by the US National Institutes of Health found that exposure to phthalates, especially di-2-ethylhexyl-phthalate (DEHP), is associated with cardiovascular changes and is a suspected disruptor of heart rhythm and blood vessel health (pmc.ncbi.nlm.nih.gov).
The mechanisms behind these risks are concerning. Phthalates absorbed into the bloodstream from medicine capsules can cause inflammation and oxidative stress in the cells lining the arteries. This leads to “hardening” or narrowing of these essential blood vessels—a condition that can trigger heart attacks, blockages, or aneurysms. The chemicals can also disrupt cholesterol balance and raise levels of triglycerides in the blood, further compounding heart disease risk (atsdr.cdc.gov, pmc.ncbi.nlm.nih.gov).
A research expert from the U.S. National Institute of Environmental Health Sciences explains: “Experimental and epidemiological studies show that phthalate exposure can lead to negative impacts on cardiovascular, endocrine, and metabolic health. However, more longitudinal data are needed before routine screening can be recommended.” Another cardiology specialist cited by the Daily Mail notes: “Phthalates can increase inflammation and an important risk for heart disease. Minimizing unnecessary use of soft gel capsules may be prudent, especially in populations with pre-existing cardiovascular risks.”
For Thailand, the warning takes on additional urgency. Rates of cardiovascular disease have steadily risen over the past two decades, making it one of the leading causes of death and disability among Thai adults (World Health Organization). While lifestyle, genetics, and diet remain major factors, new threats such as chemical exposures from pharmaceuticals add another layer of risk that is mostly invisible to consumers. In Thai pharmacies, soft gel capsules are often marketed as a more palatable or premium option, especially for children, the elderly, or those with difficulty swallowing traditional tablets—groups that may also be most vulnerable to the effects of phthalates.
The cultural context complicates the issue. Traditional Thai medicine and local herbal commonsense frequently intersect with Western pharmaceuticals, often without clear guidance about long-term safety or cumulative exposure. There is relatively little consumer awareness about inactive ingredients in medications—such as capsule shell materials—compared to other food or drug additives. Thai regulatory agencies have set some limits on phthalates in food packaging and children’s toys, in line with international standards, but regulations around their use in medications remain less comprehensive (Wikipedia).
Looking forward, experts predict increased scrutiny and possible regulation of phthalate use in pharmaceutical manufacturing worldwide. Some countries and manufacturers are already developing alternative capsule shell materials less reliant on plasticizers—such as hydroxypropyl methylcellulose (HPMC)—which could help reduce consumer exposure over time (csun.edu). For Thailand, ongoing dialogue between public health officials, regulators, prescribers, and manufacturers will be necessary to assess risks, promote transparent labeling, and identify safer alternatives where possible.
For Thai readers, the takeaway is both simple and urgent: consult with pharmacists or healthcare professionals before choosing any regular medication, especially soft gel capsules. Ask about inactive ingredients and whether non-phthalate alternatives are available. For those managing chronic conditions or at high risk of heart disease, consider discussing with your doctor whether switching to phthalate-free medicines is warranted, and always follow evidence-based medical guidance. As the science continues to evolve, education and awareness are the best tools to minimize hidden health risks in everyday medicines.
Sources: